发明名称 IMIDAZOLIDINEDIONE DERIVATIVES
摘要 The invention provides a compound of formula (Ia), and pharmaceutically acceptable salts thereof. The invention also provides use of the compounds or salts as modulators of Kv3.1 and/or Kv3.2, and in the treatment of diseases or disorders where a modulator of Kv3.1 and/or Kv3.2 is required, such as depression and mood disorders, hearing disorders, schizopherenea, substance abuse disorders, sleep disorders or epilepsy.
申请公布号 US2017065585(A1) 申请公布日期 2017.03.09
申请号 US201615348091 申请日期 2016.11.10
申请人 AUTIFONY THERAPEUTICS LIMITED 发明人 ALVARO Giuseppe;DECOR Anne;FONTANA Stefano;HAMPRECHT Dieter;LARGE Charles;MARASCO Agostino
分类号 A61K31/506;A61K31/4166;A61K31/4439 主分类号 A61K31/506
代理机构 代理人
主权项 1. A method of treating schizophrenia, which comprises administering to a subject in need thereof an effective amount a compound of formula (Ia): wherein: R1 is halo, C1-4 alkyl, C1-4 alkoxy, halo-C1-4alkyl, halo-C1-4alkoxy, or cyano; R2 is H, halo, cyano, C1-4 alkyl or C1-4 alkoxy; with the proviso that when R2 is H, R1 is not in the para position; X is CH or N; Y is CH or N; R3 is C1-4 alkyl; R4 is H, deuterium, or C1-4alkyl; or R3 and R4 can be fused to form a C3-4 spiro carbocyclyl group; or a pharmaceutically acceptable salt thereof.
地址 London GB